أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

biogen idec australia pty ltd - natalizumab -

أستراليا - الإنجليزية - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bugs for bugs pty ltd - 3-methyl-1-butanol; 2-methyl-1-butanol; ethyl acetate; acetaldehyde; sec butanol; ethanol; carpophilus aggregation pheromones - bait - 3-methyl-1-butanol active 0.0 g/l; 2-methyl-1-butanol active 0.0 g/l; ethyl acetate solvent active 0.0 g/l; acetaldehyde r1 active 0.0 g/l; sec butanol r2 active 0.0 g/l; ethanol alcohol active 0.0 g/l; carpophilus aggregation pheromones biological-pheromone active 15.0 mg/lure - insecticide - apple | apricot | berry fruit | cherry | nashi pear | nectarine | peach | pear | plum | delicious | golden delicious | granny sm - monitoring & management of carpophilus b | ^corpophilus beetles | ^monitoring and manegment of | c. davidsoi | c. hemipterus | c. mutilatus

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

leo pharma limited - calcipotriol 50 µg/ml - topical solution - 50 mcg/g - active: calcipotriol 50 µg/ml excipient: hyprolose isopropyl alcohol levomenthol propylene glycol purified water sodium citrate dihydrate

كندا - الإنجليزية - Health Canada

abbvie corporation - linaclotide - capsule - 145mcg - linaclotide 145mcg - miscellaneous gi drugs

كندا - الإنجليزية - Health Canada

abbvie corporation - linaclotide - capsule - 290mcg - linaclotide 290mcg - miscellaneous gi drugs

كندا - الإنجليزية - Health Canada

sucampo pharma americas llc - lubiprostone - capsule - 24mcg - lubiprostone 24mcg - miscellaneous gi drugs

كندا - الإنجليزية - Health Canada

glaxosmithkline inc - mepolizumab - powder for solution - 100mg - mepolizumab 100mg - immunosuppressive agents

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc. - mitoxantrone hydrochloride (unii: u6usw86rd0) (mitoxantrone - unii:bz114nvm5p) - mitoxantrone 2 mg in 1 ml

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

hospira, inc. - mitoxantrone hydrochloride (unii: u6usw86rd0) (mitoxantrone - unii:bz114nvm5p) - mitoxantrone 2 mg in 1 ml - mitoxantrone is indicated for reducing neurologic disability and/or the frequency of clinical relapses in patients with secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis (i.e., patients whose neurologic status is significantly abnormal between relapses). mitoxantrone is not indicated in the treatment of patients with primary progressive multiple sclerosis. the clinical patterns of multiple sclerosis in the studies were characterized as follows: secondary progressive and progressive relapsing disease were characterized by gradual increasing disability with or without superimposed clinical relapses, and worsening relapsing-remitting disease was characterized by clinical relapses resulting in a step-wise worsening of disability. mitoxantrone in combination with corticosteroids is indicated as initial chemotherapy for the treatment of patients with pain related to advanced hormone-refractory prostate cancer. mitoxantrone in combination with other approved

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

teva parenteral medicines, inc. - mitoxantrone hydrochloride (unii: u6usw86rd0) (mitoxantrone - unii:bz114nvm5p) - mitoxantrone 2 mg in 1 ml - mitoxantrone injection usp (concentrate) is indicated for reducing neurologic disability and/or the frequency of clinical relapses in patients with secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis (i.e., patients whose neurologic status is significantly abnormal between relapses). mitoxantrone injection usp (concentrate) is not indicated in the treatment of patients with primary progressive multiple sclerosis. the clinical patterns of multiple sclerosis in the studies were characterized as follows: secondary progressive and progressive relapsing disease were characterized by gradual increasing disability with or without superimposed clinical relapses, and worsening relapsing-remitting disease was characterized by clinical relapses resulting in a step-wise worsening of disability. mitoxantrone injection usp (concentrate) in combination with corticosteroids is indicated as initial chemotherapy for the treatment of patients with pain related to advanced